Osteoarthritis Therapeutics Market by Drug Type (Viscosupplementation Agents, Analgesics, Non-steroidal Anti-inflammatory Drugs, and Corticosteroids), by Anatomy (Knee Osteoarthritis, Hand Osteoarthritis, Hip Osteoarthritis, and Small Joint Osteoarthritis), by Route of Administration (Parenteral Route, Oral Route, and Topical Route), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Global Outlook & Forecast 2022-2030
- Category: Healthcare
- Published Date: Sep 2022
- Publisher: Growth Plus Reports
- Pages: 119
The Osteoarthritis Therapeutics Market is predicted to reach US$ by 2030 from US$ 7.93 billion in 2021, and to grow at a CAGR of 8.7% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
Drug Type (Viscosupplementation Agents, Analgesics, Non-steroidal Anti-inflammatory Drugs, and Corticosteroids), by Anatomy (Knee Osteoarthritis, Hand Osteoarthritis, Hip Osteoarthritis, and Small Joint Osteoarthritis), by Route of Administration (Parenteral Route, Oral Route, and Topical Route), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Pfizer Inc., Johnson & Johnson Services, Inc., Sanofi, Bayer AG, Abbott, Horizon Therapeutics plc, GlaxoSmithKline Plc., Zimmer Biomet Holdings Inc., Novartis AG, and and Flexion Therapeutics Inc., among others
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
Drug Type (Viscosupplementation Agents, Analgesics, Non-steroidal Anti-inflammatory Drugs, and Corticosteroids), by Anatomy (Knee Osteoarthritis, Hand Osteoarthritis, Hip Osteoarthritis, and Small Joint Osteoarthritis), by Route of Administration (Parenteral Route, Oral Route, and Topical Route), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Pfizer Inc., Johnson & Johnson Services, Inc., Sanofi, Bayer AG, Abbott, Horizon Therapeutics plc, GlaxoSmithKline Plc., Zimmer Biomet Holdings Inc., Novartis AG, and and Flexion Therapeutics Inc., among others
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years – 2020
2. Base Year – 2021
3. Forecasted Years – 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Osteoarthritis Therapeutics - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Osteoarthritis Therapeutics - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Osteoarthritis Therapeutics - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Osteoarthritis Therapeutics - ANALYSIS & FORECAST, BY REGION
North America Osteoarthritis Therapeutics
1. North America Osteoarthritis Therapeutics , by Country
1. US
2. Canada
1. North America Osteoarthritis Therapeutics , by Product
2. North America Osteoarthritis Therapeutics , by Type
3. North America Osteoarthritis Therapeutics , by Gender
4. North America Osteoarthritis Therapeutics , by Sales Channel
3. Europe Osteoarthritis Therapeutics
1. Europe Osteoarthritis Therapeutics , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Osteoarthritis Therapeutics , by Product
3. Europe Osteoarthritis Therapeutics , by Type
4. Europe Osteoarthritis Therapeutics , by Gender
5. Europe Osteoarthritis Therapeutics , by Sales Channel
4. Asia Pacific Osteoarthritis Therapeutics
1. Asia Pacific Osteoarthritis Therapeutics , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Osteoarthritis Therapeutics , by product
3. Asia Pacific Osteoarthritis Therapeutics , by Type
4. Asia Pacific Osteoarthritis Therapeutics , by Gender
5. Asia Pacific Osteoarthritis Therapeutics , by Sales Channel
5. Rest of the World Osteoarthritis Therapeutics
1. Rest of the World Osteoarthritis Therapeutics , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Osteoarthritis Therapeutics , by Product
3. Rest of the World Osteoarthritis Therapeutics , by Type
4. Rest of the World Osteoarthritis Therapeutics , by Gender
5. Rest of the World Osteoarthritis Therapeutics , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 56
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years – 2020
2. Base Year – 2021
3. Forecasted Years – 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Osteoarthritis Therapeutics - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Osteoarthritis Therapeutics - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Osteoarthritis Therapeutics - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Osteoarthritis Therapeutics - ANALYSIS & FORECAST, BY REGION
North America Osteoarthritis Therapeutics
1. North America Osteoarthritis Therapeutics , by Country
1. US
2. Canada
1. North America Osteoarthritis Therapeutics , by Product
2. North America Osteoarthritis Therapeutics , by Type
3. North America Osteoarthritis Therapeutics , by Gender
4. North America Osteoarthritis Therapeutics , by Sales Channel
3. Europe Osteoarthritis Therapeutics
1. Europe Osteoarthritis Therapeutics , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Osteoarthritis Therapeutics , by Product
3. Europe Osteoarthritis Therapeutics , by Type
4. Europe Osteoarthritis Therapeutics , by Gender
5. Europe Osteoarthritis Therapeutics , by Sales Channel
4. Asia Pacific Osteoarthritis Therapeutics
1. Asia Pacific Osteoarthritis Therapeutics , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Osteoarthritis Therapeutics , by product
3. Asia Pacific Osteoarthritis Therapeutics , by Type
4. Asia Pacific Osteoarthritis Therapeutics , by Gender
5. Asia Pacific Osteoarthritis Therapeutics , by Sales Channel
5. Rest of the World Osteoarthritis Therapeutics
1. Rest of the World Osteoarthritis Therapeutics , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Osteoarthritis Therapeutics , by Product
3. Rest of the World Osteoarthritis Therapeutics , by Type
4. Rest of the World Osteoarthritis Therapeutics , by Gender
5. Rest of the World Osteoarthritis Therapeutics , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 56
no record found